Marshall Wace
LUNG icon

Marshall Wace’s Pulmonx LUNG Stock Holding History

Marshall Wace’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$300K Buy
+230,738
New +$318K ﹤0.01% 2718
2025
Q3 		– Sell
-189,730
Closed -$491K – 3179
2025
Q2 		$491K Sell
189,730
-270,212
-59% -$1.07M ﹤0.01% 2152
2025
Q1 		$3.1M Buy
+459,942
New +$3.26M ﹤0.01% 1272
2024
Q4 		– Sell
-57,109
Closed -$473K – 2827
2024
Q3 		$473K Buy
+57,109
New +$413K ﹤0.01% 1939
2024
Q2 		– Sell
-123,313
Closed -$1.14M – 2774
2024
Q1 		$1.14M Buy
123,313
+38,526
+45% +$452K ﹤0.01% 1601
2023
Q4 		$1.08M Sell
84,787
-71,099
-46% -$741K ﹤0.01% 1448
2023
Q3 		$1.61M Buy
+155,886
New +$1.81M ﹤0.01% 1321
2023
Q2 		– Sell
-117,268
Closed -$1.31M – 2750
2023
Q1 		$1.31M Buy
117,268
+84,787
+261% +$837K ﹤0.01% 1685
2022
Q4 		$274K Buy
+32,481
New +$309K ﹤0.01% 2594
2022
Q3 		– Sell
-15,341
Closed -$226K – 3602
2022
Q2 		$226K Buy
+15,341
New +$316K ﹤0.01% 3134
2021
Q3 		– Sell
-22,968
Closed -$1.01M – 3258
2021
Q2 		$1.01M Buy
+22,968
New +$1M ﹤0.01% 1795

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ECM
ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Marshall Wace's LUNG Position: Q2 2026 in Review

Marshall Wace opened a new position in Pulmonx (LUNG) in Q2 2026: 230,738 shares worth $300K. The stake represents ﹤0.01% of the portfolio and ranks #2718 among its holdings. This is a return to the name: Marshall Wace previously reported a position in LUNG as recently as Q2 2025.

Marshall Wace first reported a position in LUNG in Q2 2021 and has held it in 11 quarters since. The position peaked at $3.1M in Q1 2025. 107 funds tracked by Wall St. Rank hold LUNG as of Q2 2026.

  • Marshall Wace held 230,738 shares of Pulmonx worth $300K as of Q2 2026.
  • Pulmonx was a new Marshall Wace position in Q2 2026.
  • Pulmonx made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #2718 holding.
  • Marshall Wace first reported a position in Pulmonx in Q2 2021 and has held it in 11 quarters since.
  • Marshall Wace's Pulmonx position peaked at $3.1M in Q1 2025.
  • 107 funds tracked by Wall St. Rank held Pulmonx as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.